Blog
New Medical Device Excise Tax: An Opportunity to Refocus Product Development
05-22-2013
Mike Rozembajgier
The 2.3 percent excise tax on the sale of all medical devices in the United States took effect January 1, 2013, and the industry has been working to adapt to the new tax. While the new tax does add an additional financial consideration for medical-device companies, these companies are identifying new ways to mitigate the affect of the tax.
05-22-2013
Mike Rozembajgier
The 2.3 percent excise tax on the sale of all medical devices in the United States took effect January 1, 2013, and the industry has been working to adapt to the new tax. While the new tax does add an additional financial consideration for medical-device companies, these companies are identifying new ways to mitigate the affect of the tax.
The FDA’s Budget Plan for Enforcing FSMA
05-20-2013
Mike Rozembajgier
The Food and Drug Administration (FDA) submitted a budget request for $4.7 billion for the 2014 fiscal year. The proposed budget, released in early April, calls for industry user fees to make up 94 percent of the budget’s nearly $500 million increase from the previous year.
05-20-2013
Mike Rozembajgier
The Food and Drug Administration (FDA) submitted a budget request for $4.7 billion for the 2014 fiscal year. The proposed budget, released in early April, calls for industry user fees to make up 94 percent of the budget’s nearly $500 million increase from the previous year.
GMA Consumer Complaints Management Conference and Building a Recall Communications Strategy
05-17-2013
Mike Rozembajgier Building out a targeted communication strategy that addresses the concerns of all stakeholders is a critical step in ensuring that a brand is protected during and following a recall event. Additionally, measuring the effectiveness of these communication efforts can highlight a company’s commitment to due diligence. Notification tactics and response rates are evidence to support agency compliance efforts and can also shape the public’s perception of a company.
05-17-2013
Mike Rozembajgier Building out a targeted communication strategy that addresses the concerns of all stakeholders is a critical step in ensuring that a brand is protected during and following a recall event. Additionally, measuring the effectiveness of these communication efforts can highlight a company’s commitment to due diligence. Notification tactics and response rates are evidence to support agency compliance efforts and can also shape the public’s perception of a company.
ExpertRECALL Quarterly Index: Now Is the Time to Address Food Safety Concerns
05-15-2013
The most recent ExpertRECALL Quarterly Index highlights the need for companies, especially food manufacturers, to pay close attention to safety standards in their supply chain. For the first time, the ExpertRECALL Quarterly Index includes data from the U.S. Department of Agriculture (USDA), which monitors recalls of meat, poultry, and egg products.
05-15-2013
The most recent ExpertRECALL Quarterly Index highlights the need for companies, especially food manufacturers, to pay close attention to safety standards in their supply chain. For the first time, the ExpertRECALL Quarterly Index includes data from the U.S. Department of Agriculture (USDA), which monitors recalls of meat, poultry, and egg products.
Antibiotics in Meat and the Fear of Superbugs
05-03-2013
Mike Rozembajgier
The Environmental Working Group (EWG) recently released a report that suggests that antibiotic-resistant bacteria, or “superbugs,” such as certain strains of salmonella, E.coli, and campylobacter, are now common in the meat sold at American supermarkets. Per EWG’s calculations, more than half of the of supermarket meat (including ground turkey, pork chops, and ground beef) has been documented to have “startlingly high levels of antibiotic-resistant bacteria.” The report was partly underwritten by Applegate, an antibiotic-free and organic natural meats company, and essentially interprets the 2011 Retail Meat Annual Report published by the National Antimicrobial Resistance Monitoring System (NARMS).
05-03-2013
Mike Rozembajgier
The Environmental Working Group (EWG) recently released a report that suggests that antibiotic-resistant bacteria, or “superbugs,” such as certain strains of salmonella, E.coli, and campylobacter, are now common in the meat sold at American supermarkets. Per EWG’s calculations, more than half of the of supermarket meat (including ground turkey, pork chops, and ground beef) has been documented to have “startlingly high levels of antibiotic-resistant bacteria.” The report was partly underwritten by Applegate, an antibiotic-free and organic natural meats company, and essentially interprets the 2011 Retail Meat Annual Report published by the National Antimicrobial Resistance Monitoring System (NARMS).
-
- GET HELP NOW
- HELP PREPARE
- RECALL INDEX
- BLOG
